Affect Therapeutics
PrivateLast Round
Series B
Nov 5, 2025
Total Funding Raised
$75.3M
Company Overview
Affect Therapeutics is a digital health company that provides a smartphone-based virtual clinic for substance use and mental health disorders, utilizing contingency management, counseling, and medication-assisted treatment.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affect Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Affect Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 5, 2025 | ||||
| Series B | Sep 23, 2025 | ||||
| Series A | Jul 12, 2023 | ||||
| Grant | Sep 30, 2021 | ||||
| Seed | Aug 31, 2021 | ||||
Seed | Apr 21, 2021 |
Key People
Founding team and executive leadership
Affect Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AlleyCorp | Seed, Series A |
| ARTIS Ventures | Series B, Series A |
| Samsung Next TLV | Series A |
| LifeArc Ventures | Series B, Series A |
| Kapor Capital | Seed |
| Acumen | Seed |
| What If Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2024
Grew 16% QoQ, from 91 to 106 employees.
- Mar 22, 2024
Grew 19% QoQ, from 83 to 99 employees.
Affect Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Affect Therapeutics's valuation, stock price, and market status.